More than 2 million Americans are addicted to prescription pain pills and street drugs. Opioids now kill more Americans than car accidents or guns. The epidemic has reached crisis mode — the U.S. Department of Health and Human Services declared a public health emergency in 2017.

How do we combat a crisis of these growing proportions? Some of the smartest minds in the world are using data science and analytics to reduce opioid usage and treat addiction.

In this 13-minute highlight reel of a South by Southwest (SXSW) panel on “Using Data Analytics to Combat the Opioid Crisis,” hear from Dean Stoecker, CEO and Chairman of Alteryx, as well as experts in healthcare, public sector, and analytics for a candid discussion around the positive impact of data analytics on the opioid epidemic and their respective approaches to fighting this crisis.

This panel recap covers:

  • How Intermountain Healthcare, a not-for-profit healthcare system, rose to its CEO’s challenge to reduce opioid prescriptions by 40 percent
  • What the Department of Health and Human Services is doing to move from “what happened” to “what is happening” with timelier data
  • How the Colorado Hospital Association is putting data into the hands of providers to drive action on the ground

When it comes to solving a crisis of this proportion, it’s either all of us or none of us. See how communities of healthcare and analytics professionals have come together to help their communities combat the crisis.

Speakers

  • Dean-CEO-small

    Dean Stoecker
    CEO
    Alteryx, Inc.

  • john-savage-small

    John Savage
    Director, Patient Safety
    Colorado Hospital Association (CHA)

  • mona-small

    Mona Siddiqui
    Chief Data Officer
    U.S. Department of Health and Human Services

  • lynsie-small

    Lynsie Daley
    Senior Data Analyst
    Intermountain Healthcare

"More than 200 people die every day from the opioid addiction problem, and we are here to leverage data science and analytics to deal with this issue once and for all."
— Dean Stoecker, CEO, Alteryx, Inc.; Panel Moderator